National Health Act 1953 Amendment determinations under sections 85, 85A and 88 pharmaceutical benefits (No. PB 30 of 2010) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 30 of 2010

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, FELICITY McNEILL, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated    26 March                            2010

FELICITY McNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences on the day after registration on the Federal Register of Legislative Instruments, and prior to the commencement of

PB 15 of 2010.

2              Amendment of PB 15 of 2010

Schedule 1 amends PB 15 of 2010.

Schedule 1            Amendments

1. Part 1 of Schedule 1, item dealing with Dabigatran etexilate

(a) omit from the column headed “Form (strength, type, size, etc.)”:

Tablet (wherever occurring)

and substitute:

Capsule

(b) omit from the column headed “Form (strength, type, size, etc.)”:

Tablets (wherever occurring)

and substitute:

Capsules